Evidence map›Paper›PMID 21063272›Full record

ReviewMolecules (Basel, Switzerland)2010

Antioxidant vitamins and their use in preventing cardiovascular disease.

Dan Farbstein, Adena Kozak-Blickstein, Andrew P Levy

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Polymer directed self-assembly of pH-responsive antioxidant nanoparticles.Langmuir : the ACS journal of surfaces and colloids · 2015
    Article
  20. Mitochondria and reactive oxygen species: physiology and pathophysiology.International journal of molecular sciences · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dan FarbsteinTechnion Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
Adena Kozak-Blickstein
Andrew P Levy

Funding

The Oxidation Hypothesis Revisited:Haptoglobin Genotype and Diabetic AtheroscleroR01DK085226 · NIDDK · TECHNION-ISRAEL INSTITUTE OF TECHNOLOGY · PI LEVY, ANDREW PETER · 2009 to 2013
$664k
NIDDK NIH HHS R01 DK085226NIDDK NIH HHS R01DK085226
6 · The paper itself

Abstract

Atherosclerosis remains one of the leading causes of death in Western populations. Subsequent to the discovery that oxidative stress plays a pivotal role in the development and progression of atherosclerosis, vitamins C and E, along with other antioxidants, were studied as potential therapies for the disease. However, while in vitro and in vivo studies showed promising antiatherogenic effects for vitamins C and E, clinical trials in which patients were given high doses of vitamin E or C showed no benefit and even possible harm. This review will attempt to summarize the known mechanistic data regarding the biochemical effects of vitamins C and E and their relevance to atherosclerosis, and offer an explanation for the failure of clinical trials to show that supplementation with these vitamins provides any benefit when given indiscriminately. We provide one example of how pharmacogenomics may be used to identify a sub-population which may indeed benefit from antioxidant supplementation.

Indexed as

AntioxidantsAscorbic AcidCardiovascular DiseasesClinical Trials as TopicHumansOxidative StressVitamin EVitaminsAntioxidantsAscorbic AcidVitamin EVitamins

Identifiers

PMID21063272
PMCPMC3602790

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.